article thumbnail

Study Finds That Medical Marijuana Patient Registration Has Grown More Than 600% Since 2016

Veriheal

million registered in 2020 and an even more dramatic rise from the 678,000 registered in 2016. This data aligns with Americans’ rising acceptance of cannabis. Policies like telemedicine, curbside pickup, and cannabis delivery made marijuana products more accessible and affordable to countless Americans.

article thumbnail

CDC Seeks Public Comments Regarding Chronic Pain Management

NORML

The call for comments, posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management. percent in 2016).”

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Finding ‘Releaf’: Put Data in Your Pipe and Smoke It

The Cannigma

When you walk into a hardware store, pharmacy, or even a liquor store, if you don’t know exactly what product will meet your needs there’s someone educated enough to point you to the right product and the data to back up that recommendation, says Tyler Dautrich, COO of Releaf. So Releaf app is an app that we released back in 2016.

Data 100
article thumbnail

CDC Still Soliciting Comments Regarding Chronic Pain Management Solutions

NORML

The agency’s call for comments, initially posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management. percent in 2016).”

article thumbnail

Psilocybin Patenting and the Threat to Patient Access

Cannabis Law Report

Mental health treatment is big business, with the global antidepressant drug market valued at over $13 billion in 2016. The FDA will likely refer to this data as it considers formal approval for psilocybin therapy and products. Threat to Patient Access in Oregon. The Race to Patent Psilocybin. info@gl-lg.com ? or 503-488-5424.

Access 52
article thumbnail

PA: Court orders release on medical cannabis data regarding, “how many medical marijuana patients have received approval from a doctor to use cannabis for opioid addiction treatment.”

Cannabis Law Report

Spotlight PA sought that data to better understand the impact of the agency’s unusual and controversial decision to endorse cannabis as a treatment option for opioid use disorder. The newsroom specifically requested aggregate data — information that would not identify individual patients.

Data 52
article thumbnail

More than half of prescriptions for medicinal cannabis in Australia given in Queensland, study says

Cannabis Law Report

Medicinal cannabis products such as capsules, creams, oils, lozenges, sprays and granulated flowers were approved for prescription 159,665 times between the start of Australia’s medicinal cannabis program in February 2016 and September 2021, research led by the University of Sydney’s Lambert Initiative for Cannabinoid Therapeutics shows.